Rivera, Cristy Joy C.

HRN: 28-12-26  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/05/2026
03/12/2026
IV
500mg
Q8H
Cholelithiasis; For Lap Chole
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines